Disorders of cardiac conduction and rhythm in patients with rheumatoid arthritis
https://doi.org/10.21886/2712-8156-2023-4-4-22-29
Abstract
The article presents data on the frequency and features of the development of various cardiac conduction and rhythm disorders in patients with rheumatoid arthritis, the mechanisms of development of these disorders, and discusses the role of inflammation, atrial remodeling, dysfunction of the autonomic nervous system, activation of the renin-angiotensin system, endothelial dysfunction and other factors.
About the Author
A. P. Rebrov
Saratov State Medical University n.a. V. I. Razumovskyy
Russian Federation
Russian Federation
Andrey P. Rebrov - MD, professor, professor of hospital therapy of general medicine Department, V.I. Razumovsky Saratov State Medical University.
Saratov
References
1. Lopez-Candales A, Hernández Burgos PM, Hernandez-Suarez DF, Harris D. Linking Chronic Inflammation with Cardiovascular Disease: From Normal Aging to the Metabolic Syndrome. J Nat Sci. 2017;3(4):e341. PMID: 28670620; PMCID: PMC5488800.
2. Mason JC, Libby P. Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. Eur Heart J. 2015;36(8):482-9c. DOI: 10.1093/eurheartj/ehu403
3. Myerburg RJ, Interian A Jr, Mitrani RM, Kessler KM, Castellanos A. Frequency of sudden cardiac death and profiles of risk. Am J Cardiol. 1997;80(5B):10F-19F. DOI: 10.1016/s0002-9149(97)00477-3
4. Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum. 2005;52(3):722-32. DOI: 10.1002/art.20878
5. Masoud S, Lim PB, Kitas GD, Panoulas V. Sudden cardiac death in patients with rheumatoid arthritis. World J Cardiol. 2017;9(7):562-573. DOI: 10.4330/wjc.v9.i7.562
6. Lazzerini PE, Capecchi PL, Laghi-Pasini F. Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis. Eur Heart J. 2017;38(22):1717-1727. DOI: 10.1093/eurheartj/ehw208
7. Myerburg RJ, Junttila MJ. Sudden cardiac death caused by coronary heart disease. Circulation. 2012;125(8):1043-52. DOI: 10.1161/CIRCULATIONAHA.111.023846
8. Karpouzas GA, Malpeso J, Choi TY, Li D, Munoz S, Budoff MJ. Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease. Ann Rheum Dis. 2014;73(10):1797-804. DOI: 10.1136/annrheumdis-2013-203617
9. Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2005;52(2):402-11. DOI: 10.1002/art.20853
10. Goodson N, Marks J, Lunt M, Symmons D. Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s. Ann Rheum Dis. 2005;64(11):1595-601. DOI: 10.1136/ard.2004.034777
11. Van Doornum S, Brand C, King B, Sundararajan V. Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis. Arthritis Rheum. 2006;54(7):2061-8. DOI: 10.1002/art.21932
12. Mantel Ä, Holmqvist M, Jernberg T, Wållberg-Jonsson S, Askling J. Rheumatoid arthritis is associated with a more severe presentation of acute coronary syndrome and worse short-term outcome. Eur Heart J. 2015;36(48):3413-22. DOI: 10.1093/eurheartj/ehv461
13. Lazzerini PE, Capecchi PL, Acampa M, Galeazzi M, Laghi-Pasini F. Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. Autoimmun Rev. 2014;13(9):936-44. DOI: 10.1016/j.autrev.2014.05.007
14. Kobayashi H, Kobayashi Y, Yokoe I, Kitamura N, Nishiwaki A, Takei M, et al. Heart Rate-corrected QT Interval Duration in Rheumatoid Arthritis and Its Reduction with Treatment with the Interleukin 6 Inhibitor Tocilizumab. J Rheumatol. 2018;45(12):1620-1627. DOI: 10.3899/jrheum.180065
15. Lazzerini PE, Laghi-Pasini F, Bertolozzi I, Morozzi G, Lorenzini S, Simpatico A, et al. Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes. Heart. 2017;103(22):1821-1829. DOI: 10.1136/heartjnl-2016-311079
16. Cindas A, Gökçe-Kutsal Y, Tokgözoglu L, Karanfil A. QT dispersion and cardiac involvement in patients with rheumatoid arthritis. Scand J Rheumatol. 2002;31(1):22-6. DOI: 10.1080/030097402317255327
17. Chauhan K, Ackerman MJ, Crowson CS, Matteson EL, Gabriel SE. Population-based study of QT interval prolongation in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2015;33(1):84-9. PMID: 25572282; PMCID: PMC4366055.
18. Adlan AM, Panoulas VF, Smith JP, Fisher JP, Kitas GD. Association between corrected QT interval and inflammatory cytokines in rheumatoid arthritis. J Rheumatol. 2015;42(3):421-8. DOI: 10.3899/jrheum.140861
19. Lazzerini PE, Acampa M, Capecchi PL, Hammoud M, Maffei S, Bisogno S, et al. Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. Eur J Intern Med. 2013;24(4):368-74. DOI: 10.1016/j.ejim.2013.02.009
20. Panoulas VF, Toms TE, Douglas KM, Sandoo A, Metsios GS, Stavropoulos-Kalinoglou A, et al. Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: an association driven by high inflammatory burden. Rheumatology (Oxford). 2014;53(1):131-7. DOI: 10.1093/rheumatology/ket338
21. Lazzerini PE, Capecchi PL, Bertolozzi I, Morozzi G, Lorenzini S, Simpatico A, et al. Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis. Front Cardiovasc Med. 2016;3:31. DOI: 10.3389/fcvm.2016.00031
22. Villecco AS, de Liberali E, Bianchi FB, Pisi E. Antibodies to cardiac conducting tissue and abnormalities of cardiac conduction in rheumatoid arthritis. Clin Exp Immunol. 1983;53(3):536-40. PMID: 6352096; PMCID: PMC1535654.
23. Kadi H, Inanir A, Habiboglu A, Ceyhan K, Koc F, Çelik A, Onalan O, Arslan S. Frequency of fragmented QRS on ECG is increased in patients with rheumatoid arthritis without cardiovascular disease: a pilot study. Mod Rheumatol. 2012;22(2):238-42. DOI: 10.1007/s10165-011-0493-9
24. Jain R, Singh R, Yamini S, Das MK. Fragmented ECG as a risk marker in cardiovascular diseases. Curr Cardiol Rev. 2014;10(3):277-86. DOI: 10.2174/1573403x10666140514103451
25. Guler H, Seyfeli E, Sahin G, Duru M, Akgul F, Saglam H, et al. P wave dispersion in patients with rheumatoid arthritis: its relation with clinical and echocardiographic parameters. Rheumatol Int. 2007;27(9):813-8. DOI: 10.1007/s00296-007-0307-8
26. Arslan S, Bozkurt E, Sari RA, Erol MK. Diastolic function abnormalities in active rheumatoid arthritis evaluation by conventional Doppler and tissue Doppler: relation with duration of disease. Clin Rheumatol. 2006;25(3):294-9. DOI: 10.1007/s10067-005-0014-3
27. Pascale V, Finelli R, Giannotti R, Coscioni E, Izzo R, Rozza F, et al. Cardiac eccentric remodeling in patients with rheumatoid arthritis. Sci Rep. 2018;8(1):5867. DOI: 10.1038/s41598-018-24323-0
28. Kobayashi Y, Giles JT, Hirano M, Yokoe I, Nakajima Y, Bathon JM, et al. Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: a pilot study. Arthritis Res Ther. 2010;12(5):R171. DOI: 10.1186/ar3131
29. Kobayashi H, Kobayashi Y, Yokoe I, Akashi Y, Takei M, Giles JT. Magnetic Resonance Imaging-Detected Myocardial Inflammation and Fibrosis in Rheumatoid Arthritis: Associations With Disease Characteristics and N-Terminal Pro-Brain Natriuretic Peptide Levels. Arthritis Care Res (Hoboken). 2017;69(9):1304-1311. DOI: 10.1002/acr.23138
30. Suthahar N, Meijers WC, Silljé HHW, de Boer RA. From Inflammation to Fibrosis-Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities. Curr Heart Fail Rep. 2017;14(4):235-250. DOI: 10.1007/s11897-017-0343-y
31. Patel KHK, Jones TN, Sattler S, Mason JC, Ng FS. Proarrhythmic electrophysiological and structural remodeling in rheumatoid arthritis. Am J Physiol Heart Circ Physiol. 2020;319(5):H1008-H1020. DOI: 10.1152/ajpheart.00401.2020
32. Kania G, Blyszczuk P, Eriksson U. Mechanisms of cardiac fibrosis in inflammatory heart disease. Trends Cardiovasc Med. 2009;19(8):247-52. DOI: 10.1016/j.tcm.2010.02.005
33. Kania G, Blyszczuk P, Stein S, Valaperti A, Germano D, Dirnhofer S, et al. Heart-infiltrating prominin-1+/CD133+ progenitor cells represent the cellular source of transforming growth factor beta-mediated cardiac fibrosis in experimental autoimmune myocarditis. Circ Res. 2009;105(5):462-70. DOI: 10.1161/CIRCRESAHA.109.196287
34. Morita N, Mandel WJ, Kobayashi Y, Karagueuzian HS. Cardiac fibrosis as a determinant of ventricular tachyarrhythmias. J Arrhythm. 2014;30(6):389-394. DOI: 10.1016/j.joa.2013.12.008
35. Tse G, Chan YW, Keung W, Yan BP. Electrophysiological mechanisms of long and short QT syndromes. Int J Cardiol Heart Vasc. 2016;14:8-13. DOI: 10.1016/j.ijcha.2016.11.006
36. Qian Y, Fei Z, Nian F. The Association Between Rheumatoid Arthritis and Atrial Fibrillation: Epidemiology, Pathophysiology and Management. Int J Gen Med. 2023;16:1899-1908. DOI: 10.2147/IJGM.S406926
37. Lindhardsen J, Ahlehoff O, Gislason GH, Madsen OR, Olesen JB, Svendsen JH, et al. Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study. BMJ. 2012;344:e1257. DOI: 10.1136/bmj.e1257
38. Kim SC, Liu J, Solomon DH. The risk of atrial fibrillation in patients with rheumatoid arthritis. Ann Rheum Dis. 2014;73(6):1091-5. DOI: 10.1136/annrheumdis-2013-203343
39. Bacani AK, Crowson CS, Roger VL, Gabriel SE, Matteson EL. Increased incidence of atrial fibrillation in patients with rheumatoid arthritis. Biomed Res Int. 2015;2015:809514. DOI: 10.1155/2015/809514
40. Argnani L, Zanetti A, Carrara G, Silvagni E, Guerrini G, Zambon A, et al. Rheumatoid Arthritis and Cardiovascular Risk: Retrospective Matched-Cohort Analysis Based on the RECORD Study of the Italian Society for Rheumatology. Front Med (Lausanne). 2021;8:745601. DOI: 10.3389/fmed.2021.745601
41. Beyer C, Tokarska L, Stühlinger M, Feuchtner G, Hintringer F, Honold S, et al. Structural Cardiac Remodeling in Atrial Fibrillation. JACC Cardiovasc Imaging. 2021;14(11):2199-2208. DOI: 10.1016/j.jcmg.2021.04.027
42. Li TYW, Yeo LLL, Ho JSY, Leow AS, Chan MY, Dalakoti M, et al. Association of Electrocardiographic P-Wave Markers and Atrial Fibrillation in Embolic Stroke of Undetermined Source. Cerebrovasc Dis. 2021;50(1):46-53. DOI: 10.1159/000512179
43. Narazaki M, Tanaka T, Kishimoto T. The role and therapeutic targeting of IL-6 in rheumatoid arthritis. Expert Rev Clin Immunol. 2017;13(6):535-551. DOI: 10.1080/1744666X.2017.1295850
44. Tascanov MB. The Relationship Between Prolidase Activity and Atrial Electromechanical Changes in Patients with Paroxysmal Atrial Fibrillation. Comb Chem High Throughput Screen. 2019;22(1):69-75. DOI: 10.2174/1386207322666190306143317
45. Meune C, Wahbi K, Assous N, Weber S, Kahan A, Allanore Y. Myocardial dysfunction in rheumatoid arthritis: a controlled tissue-Doppler echocardiography study. J Rheumatol. 2007;34(10):2005-9. PMID: 17787044.
46. Alcalde Ó, Cabrera Gómez S, Vallès Gras E, Benito Villabriga B, Zuccarino F, Martí-Almor J. Rheumatoid Arthritis With Severe Atrial Fibrosis and Multiple Atrial Arrhythmias: Chronic Atrial Myocarditis? Rev Esp Cardiol (Engl Ed). 2018;71(5):396-397. (In English, Spanish). DOI: 10.1016/j.rec.2017.04.003
47. Bertelsen L, Diederichsen SZ, Haugan KJ, Brandes A, Graff C, Krieger D, et al. Left Atrial Late Gadolinium Enhancement is Associated With Incident Atrial Fibrillation as Detected by Continuous Monitoring With Implantable Loop Recorders. JACC Cardiovasc Imaging. 2020;13(8):1690-1700. Erratum in: JACC Cardiovasc Imaging. 2021;14(2):523-524. DOI: 10.1016/j.jcmg.2020.03.024.
48. Ma J, Chen Q, Ma S. Left atrial fibrosis in atrial fibrillation: Mechanisms, clinical evaluation and management. J Cell Mol Med. 2021;25(6):2764-2775. DOI: 10.1111/jcmm.16350
49. Bradham W, Ormseth MJ, Elumogo C, Palanisamy S, Liu CY, Lawson MA, et al. Absence of Fibrosis and Inflammation by Cardiac Magnetic Resonance Imaging in Rheumatoid Arthritis Patients with Low to Moderate Disease Activity. J Rheumatol. 2018;45(8):1078-1084. DOI: 10.3899/jrheum.170770
50. Chan YH, Chang GJ, Lai YJ, Chen WJ, Chang SH, Hung LM, et al. Atrial fibrillation and its arrhythmogenesis associated with insulin resistance. Cardiovasc Diabetol. 2019;18(1):125. DOI: 10.1186/s12933-019-0928-8
51. Koopman FA, van Maanen MA, Vervoordeldonk MJ, Tak PP. Balancing the autonomic nervous system to reduce inflammation in rheumatoid arthritis. J Intern Med. 2017;282(1):64-75. DOI: 10.1111/joim.12626
52. Adlan AM, Paton JF, Lip GY, Kitas GD, Fisher JP. Increased sympathetic nerve activity and reduced cardiac baroreflex sensitivity in rheumatoid arthritis. J Physiol. 2017;595(3):967-981. DOI: 10.1113/JP272944
53. Zhao J, Chen M, Zhuo C, Huang Y, Zheng L, Wang Q. The Effect of Renin-Angiotensin System Inhibitors on the Recurrence of Atrial Fibrillation After Catheter Ablation. Int Heart J. 2020;61(6):1174-1182. DOI: 10.1536/ihj.20-346
54. Braz NFT, Pinto MRC, Vieira ÉLM, Souza AJ, Teixeira AL, Simões-E-Silva AC, et al. Renin-angiotensin system molecules are associated with subclinical atherosclerosis and disease activity in rheumatoid arthritis. Mod Rheumatol. 2021;31(1):119-126. DOI: 10.1080/14397595.2020.1740418
55. Khajeh Pour S, Scoville C, Tavernier SS, Aghazadeh-Habashi A. Plasma angiotensin peptides as biomarkers of rheumatoid arthritis are correlated with anti-ACE2 auto-antibodies level and disease intensity. Inflammopharmacology. 2022;30(4):1295-1302. DOI: 10.1007/s10787-022-01008-9
56. Corban MT, Godo S, Burczak DR, Noseworthy PA, Toya T, Lewis BR, et al. Coronary Endothelial Dysfunction Is Associated With Increased Risk of Incident Atrial Fibrillation. J Am Heart Assoc. 2020;9(8):e014850. DOI: 10.1161/JAHA.119.014850
57. Bassu S, Zinellu A, Sotgia S, Mangoni AA, Floris A, Farina G, et al. Oxidative Stress Biomarkers and Peripheral Endothelial Dysfunction in Rheumatoid Arthritis: A Monocentric Cross-Sectional Case-Control Study. Molecules. 2020;25(17):3855. DOI: 10.3390/molecules25173855
58. Akhmedov A, Crucet M, Simic B, Kraler S, Bonetti NR, Ospelt C, et al. TNFα induces endothelial dysfunction in rheumatoid arthritis via LOX-1 and arginase 2: reversal by monoclonal TNFα antibodies. Cardiovasc Res. 2022;118(1):254-266. DOI: 10.1093/cvr/cvab005
59. Iten L, Carroz P, Domenichini G, Graf D, Herrera C, Le Bloa M, et al. Tissu adipeux épicardique et fibrillation auriculaire [Epicardial adipose tissue and atrial fibrillation]. Rev Med Suisse. 2022;18(783):1048-1051. (In French). DOI: 10.53738/REVMED.2022.18.783.1048
60. Fatma E, Bunyamin K, Savas S, Mehmet U, Selma Y, Ismail B, et al. Epicardial fat thickness in patients with rheumatoid arthritis. Afr Health Sci. 2015;15(2):489-95. DOI: 10.4314/ahs.v15i2.23
61. Szumilas K, Szumilas P, Słuczanowska-Głąbowska S, Zgutka K, Pawlik A. Role of Adiponectin in the Pathogenesis of Rheumatoid Arthritis. Int J Mol Sci. 2020;21(21):8265. DOI: 10.3390/ijms21218265
Review
For citations:
Rebrov A.P. Disorders of cardiac conduction and rhythm in patients with rheumatoid arthritis. South Russian Journal of Therapeutic Practice. 2023;4(4):22-29. (In Russ.) https://doi.org/10.21886/2712-8156-2023-4-4-22-29
Views:
795
Email this article 